ID24819A - TURUNAN ASAM α-HIDROSIKARBOKSILAT TERSUBSTITUSI SECARA HETEROSIKLIK, PEMBUATAN DAN PENGGUNAANNYA SEBAGAI ANTAGONIS RESEPTOR ENDOTELIN - Google Patents

TURUNAN ASAM α-HIDROSIKARBOKSILAT TERSUBSTITUSI SECARA HETEROSIKLIK, PEMBUATAN DAN PENGGUNAANNYA SEBAGAI ANTAGONIS RESEPTOR ENDOTELIN

Info

Publication number: ID24819A
Authority: ID; Indonesia
Prior art keywords: herthiciclic; endoteline; substitution; making; receptor antagonists
Prior art date: 1997-11-14

Application number

IDW20000882A

Other languages

English (en)

Inventor

Wilhelm Amberg

Rolf Jansen

Heinz Hillen

Stefan Hergenroder

Manfred Raschack

Liliane Unger

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-14

Filing date

1998-11-04

Publication date

2000-08-24

1998-11-04 Application filed by Basf Ag filed Critical Basf Ag

2000-08-24 Publication of ID24819A publication Critical patent/ID24819A/id

Links

239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1
238000006467 substitution reaction Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IDW20000882A 1997-11-14 1998-11-04 TURUNAN ASAM α-HIDROSIKARBOKSILAT TERSUBSTITUSI SECARA HETEROSIKLIK, PEMBUATAN DAN PENGGUNAANNYA SEBAGAI ANTAGONIS RESEPTOR ENDOTELIN ID24819A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19750529A DE19750529A1 (de)	1997-11-14	1997-11-14	Neue heterocyclisch substituierte alpha-Hydroxycarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten
PCT/EP1998/007026 WO1999025701A1 (de)	1997-11-14	1998-11-04	NEUE HETEROCYCLISCH SUBSTITUIERTE α-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN

Publications (1)

Publication Number	Publication Date
ID24819A true ID24819A (id)	2000-08-24

Family

ID=7848772

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20000882A ID24819A (id)	1997-11-14	1998-11-04	TURUNAN ASAM α-HIDROSIKARBOKSILAT TERSUBSTITUSI SECARA HETEROSIKLIK, PEMBUATAN DAN PENGGUNAANNYA SEBAGAI ANTAGONIS RESEPTOR ENDOTELIN

Country Status (23)

Country	Link
US (1)	US6358983B1 (id)
EP (1)	EP1037883A1 (id)
JP (1)	JP2001523671A (id)
KR (1)	KR20010032083A (id)
CN (1)	CN1278805A (id)
AR (1)	AR017581A1 (id)
AU (1)	AU752165B2 (id)
BG (1)	BG104400A (id)
BR (1)	BR9814157A (id)
CA (1)	CA2308746A1 (id)
CO (1)	CO4990973A1 (id)
DE (1)	DE19750529A1 (id)
HR (1)	HRP980591A2 (id)
HU (1)	HUP0004341A3 (id)
ID (1)	ID24819A (id)
IL (1)	IL135461A0 (id)
NO (1)	NO20002154L (id)
NZ (1)	NZ504289A (id)
PL (1)	PL340756A1 (id)
SK (1)	SK4932000A3 (id)
TR (1)	TR200001365T2 (id)
WO (1)	WO1999025701A1 (id)
ZA (1)	ZA9810425B (id)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005118166A2 (en)	2004-06-04	2005-12-15	Teva Pharmaceutical Industries, Ltd.	Pharmaceutical composition containing irbesartan
MY146830A (en) *	2005-02-11	2012-09-28	Novartis Ag	Combination of organic compounds
US7790770B2 (en) *	2005-11-23	2010-09-07	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
IL296510A (en) *	2020-03-25	2022-11-01	Basf Se	Dioxazolines and their use as herbicides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19533023B4 (de)	1994-10-14	2007-05-16	Basf Ag	Neue Carbonsäurederivate, ihre Herstellung und Verwendung

1997
- 1997-11-14 DE DE19750529A patent/DE19750529A1/de not_active Withdrawn
1998
- 1998-11-04 CN CN98811085A patent/CN1278805A/zh active Pending
- 1998-11-04 EP EP98958900A patent/EP1037883A1/de not_active Withdrawn
- 1998-11-04 SK SK493-2000A patent/SK4932000A3/sk unknown
- 1998-11-04 TR TR2000/01365T patent/TR200001365T2/xx unknown
- 1998-11-04 AU AU14878/99A patent/AU752165B2/en not_active Ceased
- 1998-11-04 US US09/530,382 patent/US6358983B1/en not_active Expired - Fee Related
- 1998-11-04 JP JP2000521084A patent/JP2001523671A/ja active Pending
- 1998-11-04 CA CA002308746A patent/CA2308746A1/en not_active Abandoned
- 1998-11-04 PL PL98340756A patent/PL340756A1/xx not_active Application Discontinuation
- 1998-11-04 BR BR9814157-0A patent/BR9814157A/pt not_active IP Right Cessation
- 1998-11-04 IL IL13546198A patent/IL135461A0/xx unknown
- 1998-11-04 WO PCT/EP1998/007026 patent/WO1999025701A1/de not_active Ceased
- 1998-11-04 NZ NZ504289A patent/NZ504289A/en unknown
- 1998-11-04 ID IDW20000882A patent/ID24819A/id unknown
- 1998-11-04 HU HU0004341A patent/HUP0004341A3/hu unknown
- 1998-11-04 KR KR1020007005207A patent/KR20010032083A/ko not_active Withdrawn
- 1998-11-09 AR ARP980105651A patent/AR017581A1/es not_active Application Discontinuation
- 1998-11-13 CO CO98067231A patent/CO4990973A1/es unknown
- 1998-11-13 ZA ZA9810425A patent/ZA9810425B/xx unknown
- 1998-11-13 HR HR19750529.5A patent/HRP980591A2/hr not_active Application Discontinuation
2000
- 2000-04-27 NO NO20002154A patent/NO20002154L/no not_active Application Discontinuation
- 2000-05-04 BG BG104400A patent/BG104400A/xx unknown

Also Published As

Publication number	Publication date
CA2308746A1 (en)	1999-05-27
ZA9810425B (en)	2000-05-15
BG104400A (en)	2001-01-31
TR200001365T2 (tr)	2000-09-21
AR017581A1 (es)	2001-09-12
CN1278805A (zh)	2001-01-03
JP2001523671A (ja)	2001-11-27
IL135461A0 (en)	2001-05-20
KR20010032083A (ko)	2001-04-16
HUP0004341A3 (en)	2001-12-28
AU752165B2 (en)	2002-09-05
NO20002154L (no)	2000-05-12
DE19750529A1 (de)	1999-05-20
US6358983B1 (en)	2002-03-19
HRP980591A2 (en)	1999-08-31
BR9814157A (pt)	2000-10-03
AU1487899A (en)	1999-06-07
HUP0004341A1 (hu)	2001-10-28
NZ504289A (en)	2002-03-01
CO4990973A1 (es)	2000-12-26
EP1037883A1 (de)	2000-09-27
WO1999025701A1 (de)	1999-05-27
PL340756A1 (en)	2001-02-26
NO20002154D0 (no)	2000-04-27
SK4932000A3 (en)	2001-02-12

Publication	Publication Date	Title
ID19623A (id)	1998-07-23	Antagonis reseptor vitronektin
DE69812096D1 (de)	2003-04-17	Neuropeptid y rezeptorantagonisten
TR199801594A3 (tr)	1999-03-22	CCR-3 reseptör antagonistleri.
ID19253A (id)	1998-06-28	Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
DK1009732T3 (da)	2003-09-22	1-Amino-alkylcyclohexan NMDA receptor antagonister
EP0986385A4 (en)	2001-05-16	GONADORELIN ANTAGONISTS
ID26774A (id)	2001-02-08	Senyawa benzimidazol, pembuatan dan penggunaannya sebagai komposisi farmasi
ATE280157T1 (de)	2004-11-15	4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
ID16742A (id)	1997-11-06	Antagonis reseptor endotelin
ID24726A (id)	2000-08-03	Antagonis-antagonis reseptor trombin
TR199600359A2 (tr)	1996-11-21	Adezyon reseptörü antagonistleri.
ID19245A (id)	1998-06-28	Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
ID22916A (id)	1999-12-16	Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin
ID26223A (id)	2000-12-07	Antagonis reseptor vitronektin
ID17266A (id)	1997-12-18	Antagonis antagonis reseptor d4 dopamin benzoksazinon
ID24162A (id)	2000-07-13	Antagonis-antagonis reseptor vitronektin
ID22838A (id)	1999-12-09	Oksazolidina sebagai antagonis 5-ht2a
ID24633A (id)	2000-07-27	Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya
ID24468A (id)	2000-07-20	2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID28811A (id)	2001-07-05	Antagonis reseptor vitronektin
ID27845A (id)	2001-04-26	Turunan tetrahidrokuilina sebagai antagonis glisilina
ID26234A (id)	2000-12-07	Turunan-turunan asam karboksilat heterosiklik, pembuatan dan penggunaannya sebagai antagonis-antagonis reseptor endotelen
ID24346A (id)	2000-07-13	Turunan asam karboksilat betha -amino dan betha -azido baru, pembuatan dan penggunaannya sebagai antagonis reseptor andotelin
ID24306A (id)	2000-07-13	Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori
ID24309A (id)	2000-07-13	2-asilaminopropanamina sebagai antagonis reseptor tachykinin